Loading...
Loading...
VVOS| Name | Value |
|---|---|
| Revenues | 4,054.0K |
| Cost of Revenue | 1,403.0K |
| Gross Profit | 2,651.0K |
| Operating Expense | 4,442.0K |
| Operating I/L | -1,936.0K |
| Other Income/Expense | 6.0K |
| Interest Income | 0.0K |
| Pretax | -1,930.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -1,930.0K |
Vivos Therapeutics, Inc. develops and commercializes non-invasive treatment alternatives for dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. The company's flagship product, the Vivos System, is a non-surgical, non-pharmaceutical treatment modality for these conditions. Additionally, Vivos Therapeutics offers the VivoScore Program, a screening and home sleep test for adults and children. The company generates revenue by marketing and selling the Vivos System to licensed professionals, primarily general dentists in the United States and Canada.
